Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: A multi-institutional study of 450 patients in Japan

Journal of Dermatology

Volumn 39, Issue 2, 2012, Pages 130-137

  Namikawa, Kenjiro ^a   Yamazaki, Naoya ^a   Nakai, Yasuo ^a   Ihn, Hironobu ^b   Tomita, Yasushi ^c   Uhara, Hisashi ^d   Takenouchi, Tatsuya ^e   Kiyohara, Yoshio ^f   Moroi, Yoichi ^g   Yamamoto, Yuhei ^h   Otsuka, Fujio ⁱ   Kamiya, Hideki ^j   Iizuka, Hajime ^k   Hatta, Naohito ^l   Kadono, Takafumi ^m  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NIIGATA CANCER CENTER HOSPITAL   (Japan)

^f SHIZUOKA CANCER CENTER   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

^h HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

^j GIFU UNIVERSITY   (Japan)

^k ASAHIKAWA MEDICAL COLLEGE   (Japan)

^l TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^m UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

melanoma; micrometastasis; prognosis; sentinel lymph node; tumor burden

Indexed keywords

TRACER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; HUMAN TISSUE; JAPANESE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROMETASTASIS; OUTCOME ASSESSMENT; PREDICTION; SCHOOL CHILD; SENTINEL LYMPH NODE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM MICROMETASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84856266872     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01318.x     Document Type: Article

References (33)

1. Johnson TM, Sondak VK, Bichakjian CK, Sabel MS,. The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol 2006; 54: 19-27. (Pubitemid 41832454)
2. Balch CM, Morton DL, Gershenwald JE, et al. Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol 2009; 60: 872-875.
3. Cascinelli N, Bombardieri E, Bufalino R, et al. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. J Clin Oncol 2006; 24: 4464-4471. (Pubitemid 46630985)
4. Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL,. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 2004; 22: 3677-3684. (Pubitemid 41095206)
5. van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg 2008; 248: 949-955.
6. Starz H, Siedlecki K, Balda BR,. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004; 11: 162S-168S.
7. Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG,. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004; 22: 3345-3349. (Pubitemid 41103692)
8. Uhara H, Takata M, Saida T,. Sentinel lymph node biopsy in Japan. Int J Clin Oncol 2009; 14: 490-496.
9. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317. (Pubitemid 44465459)
10. Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL,. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004; 17: 747-755. (Pubitemid 38843356)
11. Vuylsteke RJ, Borgstein PJ, van Leeuwen PA, et al. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma. Ann Surg Oncol 2005; 12: 440-448. (Pubitemid 40884258)
12. Frankel TL, Griffith KA, Lowe L, et al. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Ann Surg Oncol 2008; 15: 2403-2411.
13. Salti GI, Das Gupta TK,. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. Am J Surg 2003; 186: 98-101. (Pubitemid 37289076)
14. Glumac N, Hocevar M, Zadnik V, Snoj M,. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients. J Surg Oncol 2008; 98: 46-48. (Pubitemid 351976953)
15. Scolyer RA, Li LX, McCarthy SW, et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 2004; 122: 532-539. (Pubitemid 39281249)
16. Sabel MS, Griffith K, Sondak VK, et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 2005; 201: 37-47. (Pubitemid 40840562)
17. Debarbieux S, Duru G, Dalle S, Beatrix O, Balme B, Thomas L,. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol 2007; 157: 58-67. (Pubitemid 46934258)
18. Cadili A, Smylie M, Danyluk J, Dabbs K,. Prediction of nonsentinel lymph node metastasis in malignant melanoma. J Surg Res 2009; 154: 324-329.
19. Cadili A, McKinnon G, Wright F, et al. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma. J Surg Oncol 2010; 101: 191-194.
20. van Akkooi AC, de Wilt JH, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 2006; 17: 1578-1585. (Pubitemid 44542045)
21. Pearlman NW, McCarter MD, Frank M, et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg 2006; 192: 878-881. (Pubitemid 44872996)
22. Govindarajan A, Ghazarian DM, McCready DR, Leong WL,. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 2007; 14: 906-912. (Pubitemid 46175342)
23. Guggenheim M, Dummer R, Jung FJ, et al. The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma-a retrospective analysis of 392 cases. Br J Cancer 2008; 98: 1922-1928. (Pubitemid 351821570)
24. Francischetto T, Spector N, Neto Rezende JF, et al. Influence of sentinel lymph node tumor burden on survival in melanoma. Ann Surg Oncol 2010; 17: 1152-1158.
25. Fink AM, Weihsengruber F, Spangl B, et al. S-classification of sentinel lymph node biopsy predicts the results of complete regional lymph node dissection. Melanoma Res 2005; 15: 267-271. (Pubitemid 41127462)
26. Rossi CR, De Salvo GL, Bonandini E, et al. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol 2008; 15: 1202-1210.
27. van der Ploeg IM, Kroon BB, Antonini N, Valdes Olmos RA, Nieweg OE,. Is completion lymph node dissection needed in case of minimal melanoma metastasis in the sentinel node? Ann Surg 2009; 249: 1003-1007.
28. Meier A, Satzger I, Volker B, Kapp A, Gutzmer R,. Comparison of classification systems in melanoma sentinel lymph nodes-an analysis of 697 patients from a single center. Cancer 2010; 116: 3178-3188.
29. Murali R, Desilva C, Thompson JF, Scolyer RA,. Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes. J Clin Oncol 2010; 28: 4441-4449.
30. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
31. Carlson GW, Murray DR, Lyles RH, Staley CA, Hestley A, Cohen C,. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003; 10: 575-581. (Pubitemid 40486923)
32. Ranieri JM, Wagner JD, Azuaje R, et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 2002; 9: 975-981. (Pubitemid 35424631)
33. Scolyer RA, Murali R, Gershenwald JE, Cochran AJ, Thompson JF,. Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell. Ann Oncol 2007; 18: 806-808. (Pubitemid 46523292)